{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:52:10Z","timestamp":1791921130844,"version":"4.3.4"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/psy.0b013e3181d2f0c8","type":"journal-article","created":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T21:31:04Z","timestamp":1267219864000},"page":"340-347","source":"Crossref","is-referenced-by-count":256,"title":["Salivary Cortisol Levels in Persons With and Without Different Anxiety Disorders"],"prefix":"10.1097","volume":"72","author":[{"given":"Sophie A.","family":"Vreeburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans G.","family":"Zitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"van Pelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel H.","family":"DeRijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda C. M.","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"van Dyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witte J. G.","family":"Hoogendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda W. J. H.","family":"Penninx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210213","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1176\/ajp.143.11.1424","article-title":"Life events and the onset of panic disorder.","volume":"143","author":"Roy-Byrne","year":"1986","journal-title":"Am J Psychiatry"},{"key":"R2-2-20210213","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease.","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 7","key":"R3-2-20210213","first-page":"5","article-title":"The neurobiology of depression: inroads to treatment and new drug discovery.","volume":"66","author":"Nemeroff","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R4-2-20210213","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.0065-1591.2000.acp29-01.x","article-title":"Anxiety and depression: the impact of shared characteristics on diagnosis and treatment. Introduction.","volume":"406","author":"Kessler","year":"2000","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R5-2-20210213","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1176\/ps.2008.59.12.1383","article-title":"Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System.","volume":"59","author":"Strine","year":"2008","journal-title":"Psychiatr Serv"},{"key":"R6-2-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1600001","article-title":"The role of corticotropin-releasing factor in depression and anxiety disorders.","volume":"160","author":"Arborelius","year":"1999","journal-title":"J Endocrinol"},{"key":"R7-2-20210213","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archpsyc.1996.01830040059010","article-title":"Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.","volume":"53","author":"Abelson","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"R8-2-20210213","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0165-1781(88)90064-9","article-title":"Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia.","volume":"24","author":"Kathol","year":"1988","journal-title":"Psychiatry Res"},{"key":"R9-2-20210213","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0165-1781(00)00183-9","article-title":"Diurnal variation of cortisol in panic disorder.","volume":"95","author":"Bandelow","year":"2000","journal-title":"Psychiatry Res"},{"key":"R10-2-20210213","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.psychres.2004.04.010","article-title":"Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking.","volume":"133","author":"Garcia-Leal","year":"2005","journal-title":"Psychiatry Res"},{"key":"R11-2-20210213","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000118890","article-title":"Psychoimmunoendocrine aspects of panic disorder.","volume":"26","author":"Brambilla","year":"1992","journal-title":"Neuropsychobiology"},{"key":"R12-2-20210213","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0306-4530(92)90003-P","article-title":"Cortisol response during different anxiogenic challenges in panic disorder patients.","volume":"17","author":"Targum","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"R13-2-20210213","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1176\/ajp.144.10.1320","article-title":"The hypothalamic-pituitary-adrenal system in panic disorder.","volume":"144","author":"Goldstein","year":"1987","journal-title":"Am J Psychiatry"},{"key":"R14-2-20210213","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1192\/bjp.164.6.818","article-title":"Panic disorder. An overlapping or independent entity?","volume":"164","author":"Okasha","year":"1994","journal-title":"Br J Psychiatry"},{"key":"R15-2-20210213","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0006-3223(86)90254-4","article-title":"Dexamethasone suppression test in patients with panic attacks.","volume":"21","author":"Bridges","year":"1986","journal-title":"Biol Psychiatry"},{"key":"R16-2-20210213","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0006-3223(91)90109-Y","article-title":"Higher postdexamethasone serum cortisol levels in agoraphobic than in nonagoraphobic panic disorder patients.","volume":"30","author":"Westberg","year":"1991","journal-title":"Biol Psychiatry"},{"key":"R17-2-20210213","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.psyneuen.2008.03.002","article-title":"Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder.","volume":"33","author":"Mantella","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"R18-2-20210213","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jad.2007.07.025","article-title":"Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes.","volume":"106","author":"Chaudieu","year":"2008","journal-title":"J Affect Disord"},{"key":"R19-2-20210213","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0033-3182(83)73157-9","article-title":"Urinary free cortisol levels in anxiety.","volume":"24","author":"Rosenbaum","year":"1983","journal-title":"Psychosomatics"},{"key":"R20-2-20210213","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000026677","article-title":"Neuroendocrine responses to psychological stress in adolescents with anxiety disorder.","volume":"42","author":"Gerra","year":"2000","journal-title":"Neuropsychobiology"},{"key":"R21-2-20210213","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1192\/bjp.149.3.320","article-title":"The dexamethasone suppression test in generalised anxiety disorder.","volume":"149","author":"Schweizer","year":"1986","journal-title":"Br J Psychiatry"},{"key":"R22-2-20210213","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-3223(88)90037-6","article-title":"The dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder.","volume":"23","author":"Tiller","year":"1988","journal-title":"Biol Psychiatry"},{"key":"R23-2-20210213","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.psychres.2005.07.003","article-title":"Involvement of GABAA receptor modulating neuroactive steroids in patients with social phobia.","volume":"137","author":"Laufer","year":"2005","journal-title":"Psychiatry Res"},{"key":"R24-2-20210213","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.psyneuen.2008.07.004","article-title":"Elevated alpha-amylase but not cortisol in generalized social anxiety disorder.","volume":"33","author":"van Veen","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"R25-2-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00127-003-0597-4","article-title":"Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders\u2014findings from the Netherlands Mental Health Survey and Incidence Study.","volume":"38","author":"de Graaf","year":"2003","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"R26-2-20210213","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archgenpsychiatry.2009.50","article-title":"Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.","volume":"66","author":"Vreeburg","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"R27-2-20210213","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mpr.256","article-title":"The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.","volume":"17","author":"Penninx","year":"2008","journal-title":"Int J Methods Psychiatr Res"},{"key":"R28-2-20210213","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000118611","article-title":"Salivary cortisol in psychobiological research: an overview.","volume":"22","author":"Kirschbaum","year":"1989","journal-title":"Neuropsychobiology"},{"key":"R29-2-20210213","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.psyneuen.2008.10.026","article-title":"Salivary cortisol as a biomarker in stress research.","volume":"34","author":"Hellhammer","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"R30-2-20210213","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.psyneuen.2009.04.024","article-title":"Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology.","volume":"34","author":"Vreeburg","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"R31-2-20210213","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0306-4530(02)00108-7","article-title":"Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change.","volume":"28","author":"Pruessner","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"R32-2-20210213","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/archpsyc.61.3.310","article-title":"Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry.","volume":"61","author":"Gueorguieva","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"R33-2-20210213","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archpsyc.1981.01780260017001","article-title":"A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.","volume":"38","author":"Carroll","year":"1981","journal-title":"Arch Gen Psychiatry"},{"key":"R34-2-20210213","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity.","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"R35-2-20210213","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties.","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"R36-2-20210213","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0005-7967(79)90041-X","article-title":"Brief standard self-rating for phobic patients.","volume":"17","author":"Marks","year":"1979","journal-title":"Behav Res Ther"},{"key":"R37-2-20210213","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.psyneuen.2007.01.008","article-title":"Is the cortisol awakening rise a response to awakening?","volume":"32","author":"Wilhelm","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"R38-2-20210213","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpsycho.2008.03.014","article-title":"The cortisol awakening response (CAR): facts and future directions.","volume":"72","author":"Fries","year":"2009","journal-title":"Int J Psychophysiol"},{"key":"R39-2-20210213","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/sj.npp.1301168","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder.","volume":"31","author":"Erhardt","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"R40-2-20210213","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0893-133X(95)00146-5","article-title":"Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder.","volume":"15","author":"Schreiber","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"2 Suppl A","key":"R41-2-20210213","first-page":"A39","article-title":"Comorbidity and its effects on panic disorder.","volume":"60","author":"Marshall","year":"1996","journal-title":"Bull Menninger Clin"},{"issue":"8","key":"R42-2-20210213","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.eurpsy.2003.03.007","article-title":"A 15-year follow-up study of patients with panic disorder.","volume":"18","author":"Andersch","year":"2003","journal-title":"Eur Psychiatry"},{"key":"R43-2-20210213","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1176\/ajp.153.1.69","article-title":"Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels.","volume":"153","author":"Abelson","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R44-2-20210213","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biopsych.2004.03.017","article-title":"Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression.","volume":"56","author":"Young","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R45-2-20210213","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2007.10.001","article-title":"The cortisol awakening response in relation to objective and subjective measures of waking in the morning.","volume":"33","author":"Dockray","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"R46-2-20210213","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/01.PSY.0000073872.85623.0C","article-title":"Salivary cortisol response during exposure treatment in driving phobics.","volume":"65","author":"Alpers","year":"2003","journal-title":"Psychosom Med"},{"key":"R47-2-20210213","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1590\/S0001-37652005000300009","article-title":"Does the panic attack activate the hypothalamic-pituitary-adrenal axis?","volume":"77","author":"Graeff","year":"2005","journal-title":"An Acad Bras Cienc"},{"key":"R48-2-20210213","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1210\/jc.2008-0496","article-title":"Salivary cortisol is related to atherosclerosis of carotid arteries.","volume":"93","author":"Dekker","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Psychosomatic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006842-201005000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:15:59Z","timestamp":1786040159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006842-201005000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/psy.0b013e3181d2f0c8","relation":{},"ISSN":["0033-3174"],"issn-type":[{"value":"0033-3174","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}